BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 23650566)

  • 1. Investigation of sequential growth factor delivery during cuprizone challenge in mice aimed to enhance oligodendrogliogenesis and myelin repair.
    Sabo JK; Aumann TD; Kilpatrick TJ; Cate HS
    PLoS One; 2013; 8(5):e63415. PubMed ID: 23650566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions.
    Sabo JK; Aumann TD; Merlo D; Kilpatrick TJ; Cate HS
    J Neurosci; 2011 Mar; 31(12):4504-10. PubMed ID: 21430151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
    Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
    J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination.
    Cate HS; Sabo JK; Merlo D; Kemper D; Aumann TD; Robinson J; Merson TD; Emery B; Perreau VM; Kilpatrick TJ
    J Neurochem; 2010 Oct; 115(1):11-22. PubMed ID: 20193041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
    Steelman AJ; Thompson JP; Li J
    Neurosci Res; 2012 Jan; 72(1):32-42. PubMed ID: 22015947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
    Fletcher JL; Wood RJ; Nguyen J; Norman EML; Jun CMK; Prawdiuk AR; Biemond M; Nguyen HTH; Northfield SE; Hughes RA; Gonsalvez DG; Xiao J; Murray SS
    J Neurosci; 2018 Aug; 38(32):7088-7099. PubMed ID: 29976621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
    Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.
    Kuboyama K; Fujikawa A; Suzuki R; Noda M
    J Neurosci; 2015 Sep; 35(35):12162-71. PubMed ID: 26338327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.
    Baxi EG; DeBruin J; Jin J; Strasburger HJ; Smith MD; Orthmann-Murphy JL; Schott JT; Fairchild AN; Bergles DE; Calabresi PA
    Glia; 2017 Dec; 65(12):2087-2098. PubMed ID: 28940645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.
    Clarner T; Parabucki A; Beyer C; Kipp M
    J Neuroendocrinol; 2011 Jul; 23(7):601-11. PubMed ID: 21507085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting Bone Morphogenetic Protein 4 Type I Receptor Signaling Promotes Remyelination by Potentiating Oligodendrocyte Differentiation.
    Govier-Cole AE; Wood RJ; Fletcher JL; Gonsalvez DG; Merlo D; Cate HS; Murray SS; Xiao J
    eNeuro; 2019; 6(2):. PubMed ID: 31028086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain.
    Paez PM; Cheli VT; Ghiani CA; Spreuer V; Handley VW; Campagnoni AT
    Glia; 2012 Jul; 60(7):1078-93. PubMed ID: 22447683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.
    El-Etr M; Rame M; Boucher C; Ghoumari AM; Kumar N; Liere P; Pianos A; Schumacher M; Sitruk-Ware R
    Glia; 2015 Jan; 63(1):104-17. PubMed ID: 25092805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination.
    Mason JL; Jones JJ; Taniike M; Morell P; Suzuki K; Matsushima GK
    J Neurosci Res; 2000 Aug; 61(3):251-62. PubMed ID: 10900072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of oligomeric proanthocyanidin in cuprizone-induced demyelination.
    Wang Q; Wang J; Yang Z; Sui R; Miao Q; Li Y; Yu J; Liu C; Zhang G; Xiao B; Ma C
    Exp Physiol; 2019 Jun; 104(6):876-886. PubMed ID: 30811744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unconventional Myosin ID is Involved in Remyelination After Cuprizone-Induced Demyelination.
    Yamazaki R; Baba H; Yamaguchi Y
    Neurochem Res; 2018 Jan; 43(1):195-204. PubMed ID: 28986688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-146a promotes remyelination in a cuprizone model of demyelinating injury.
    Zhang J; Zhang ZG; Lu M; Wang X; Shang X; Elias SB; Chopp M
    Neuroscience; 2017 Apr; 348():252-263. PubMed ID: 28237816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
    Tanaka T; Murakami K; Bando Y; Yoshida S
    J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.